Users of electronic toothbrushes beware. The FDA released a consumer update warning users of the Arm & Hammer Spin Brush, also known as the Crest Spinbrush, of unexpected dangers. The FDA alerts consumers that parts of the device may pop off and could chip your tooth, fly into your eye, or get stuck in your throat.
According to a consumer safety officer at the FDA, “It’s important that consumers know how to avoid the risks associated with using the Spinbrush. We’ve had reports in which parts of the toothbrush broke off during use and were released into the mouth with great speed, causing broken teeth and presenting a choking hazard.”
Toothbrushes, both manual and electric, are regulated by the Food and Drug Administration as medical devices used to help prevent tooth decay. The FDA states that safety precautions should be taken with electric toothbrushes.
The manufacturer of the SSRI drug Zoloft has filed a motion to merge all federal Zoloft lawsuits related to Zoloft birth defects. Pfizer Pharmaceuticals is requesting that the Zoloft lawsuits be combined and presented before one judge.
A study has revealed a link between nursing home residents with dementia who have used an SSRI drug and an increased risk of a fall resulting in injury when compared to residents who have not used an SSRI. According to the authors of the study, SSRI drugs, even when taken in low doses, have shown an association with an increased risk of a fall resulting in injury in nursing home residents with dementia.
When an SSRI drug is taken in combination with a hypnotic or sedative, the risk increases even more, according to the study.
This study, published in the British Journal of Clinical Pharmacology, analyzed “daily drug use and daily falls over a 2-year period” in close to 250 nursing home residents diagnosed with dementia. The average age of the residents in the study was 82 years old.
According to the FDA, manufacturers have been asked to perform more studies in order to acquire additional information on the safety of transvaginal mesh, a surgical mesh device used in pelvic organ prolapse (POP) treatment.
In July of 2011, the FDA released a safety warning regarding the serious complications associated with transvaginal placement of surgical mesh for pelvic organ prolapse. The warning explained that mesh used in transvaginal POP repair is associated with risks that are not apparent in traditional, non-mesh surgery for POP repair. The FDA also noted that the use of transvaginal mesh may not work better than a traditional POP repair without mesh.
Three couples have filed lawsuits that claim Takeda Pharmaceutical Company Limited, the manufacturer of Actos, hid the fact that the drug has been associated with a risk of cancer.
The three men involved in the suit claim to have taken Actos daily as a part of their type-2 diabetes treatment given to them by their doctor. It took several years for the men learned of the association between the blood-sugar lowering medication and increased risk of developing bladder cancer.
According to the complaint, all three men involved in the lawsuit have been diagnosed with bladder cancer since taking Actos.
Drug safety officials on July 8, 2008, imposed the government’s most urgent warning on Cipro and similar antibiotics. Officials cited evidence that they may lead to tendon ruptures, a serious injury which can leave patients incapacitated and needing extensive surgery.
The FDA ordered makers of flouroquinolone drugs — a potent class of antibacterials — to add a very visible “black box” warning to their products and write new literature warning patients.
The two leading drugs covered by the warning are Bayer’s Cipro and Ortho-McNeil’s Levaquin. Cipro became a household name during the hysteria after the anthrax attacks of 2001. Cipro is thought to be effective against that bacteria, and it’s among the medications stockpiled by the government. In everyday medicine, Cipro is often used to treat urinary tract infections. Levaquin is generally used to treat respiratory infections.